So-Young International Inc. Files Annual Report for Fiscal Year 2025

So-Young International Inc. Files Annual Report on Form 20-F

On April 23, 2026, So-Young International Inc. (Nasdaq: SY), a prominent aesthetic treatment platform based in China, disclosed its annual report on Form 20-F for the fiscal year that concluded on December 31, 2025. This filing was submitted to the U.S. Securities and Exchange Commission (SEC), showcasing the company's financial health and operational strategies.

So-Young has established itself as a pivotal bridge between consumers seeking aesthetic treatments and the service providers who deliver these services, both online and offline. By leveraging a robust online platform and a network of branded aesthetic centers, So-Young simplifies access to various aesthetic treatments, offering detailed treatment information, online reservation capabilities, and ensuring high-quality service delivery. This integrated approach has not only enhanced customer experience but has also solidified So-Young's reputation within the medical aesthetics industry.

The annual report is accessible to the public on So-Young's investor relations website: So-Young Investor Relations. Additionally, shareholders and ADS holders can request a hard copy of the report, including audited consolidated financial statements, free of charge by contacting the company directly at investor relations.

Company Background

So-Young International Inc. operates as the leading aesthetic treatment platform in China, adeptly connecting consumers with aesthetic services providers. The platform offers a well-curated selection of treatment options, allowing users to make informed decisions. Its accessible online interface and extensive offline network create an efficient ecosystem where consumers can easily find, book, and experience aesthetic treatments.

The company's innovations extend beyond mere service provision; it also develops, manufactures, and distributes cutting-edge optoelectronic medical equipment and injectable products that further empower the aesthetic treatment landscape.

Through strategic positioning, So-Young aims to capture a larger market share in the expanding medical aesthetic value chain. The company's strong brand presence, digital outreach, and commitment to affordable high-quality services have made it a go-to option for consumers in China seeking aesthetic solutions.

Future Outlook

Looking ahead, So-Young is poised for growth as it continues to navigate the dynamic landscape of medical aesthetics. The company remains keen on expanding its service offerings and enhancing user engagement to retain and grow its customer base. This dedication, coupled with strong operational strategy, positions So-Young well for sustainable growth against a backdrop of increasing competition and evolving consumer preferences.

The report also contains forward-looking statements concerning the company's future plans and operational strategies, embodying the spirit of transparency required in the contemporary financial disclosure framework. Investors and stakeholders are encouraged to review these insights for a better understanding of the company's positioning and future direction.

As the competitive landscape for aesthetic treatment services continues to evolve, So-Young's ability to adapt and innovate will be crucial. The ongoing commitment to provide high-quality treatment options and responsiveness to consumer needs reflects the company's long-term vision in a rapidly changing market.

In conclusion, So-Young International Inc.'s filing of its annual report marks a significant step in reinforcing its credibility and commitment to transparency within the investment community. Interested parties can reach out for copies of the report or additional information through the investor relations department.

For media inquiries, So-Young's investor relations contact, Ms. Mona Qiao, can be reached at +86-10-8790-2012 or via email at [email protected]. Inquiries regarding financial matters can also be directed to Ms. Charlie Chi at +86-10-5900-1548 or [email protected].